Announced Wed, 24 Jun · 17:45 IST
Trading window closure from July 1, 2026 until Q1 FY27 results
Compliance View source PDF
STAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-0.6%1-day move
₹1111.40
prior close
₹1118.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0-0.2-0.6-0.5-0.6-1.7-1.1+1.6+1.3+1.9-1.2-6.1——
Up moveDown movePending
AI summary
Strides Pharma Science has informed exchanges that its trading window will remain closed from July 1, 2026, until 48 hours after the company declares financial results for the quarter ended June 30, 2026 (Q1 FY27). This is a standard SEBI compliance requirement under insider trading regulations. The date of the Board meeting to approve these results will be announced separately. During this period, insiders and designated employees cannot trade in company shares.
Likely market impact
Routine insider trading compliance. Insiders cannot trade shares until Q1 FY27 results are declared plus 48 hours. No material impact on shareholders.